It has also been reported that in comparison with healthy controls, fetuin-B levels are substantially increased in patients with nonalcoholic fatty liver disease, T2DM, polycystic ovary syndrome, and gestational diabetes mellitus [11–13]. The gene discussed is FETUB; the disease is metabolic dysfunction-associated steatotic liver disease.